index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques Accéder directement au contenu

Dernières publications

Chiffres clés

55 Publications with fulltext

Open Access

46 %

Mots clés

Experimental autoimmune myasthenia gravis EAMG Immunotherapy DICER Cellules th17 Myoblasts Germinal center Antimir-150 Transcriptome Thymus Genetics Immunity Myasthénie grave Acides nucléiques endogènes Myasthenia gravis Mass cytometry CyTOF Genetic associations Interferon IFN Human myoblasts M3243AG Immune regulation COVID-19 Autoimmunity Experimental models Thymic epithelial cells B cells Anticorps monoclonal Inflammation Innate immunity Endogenous nucleic acids AChR antibodies Il-23 Complete Freund's adjuvant Disease susceptibility Ectopic germinal centers Gender Gd T cells Interleukin 23 Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Long-term follow-up BAFF Autoimmune diseases Chronicity Experimental mouse models Myasthenia Gravis MG Heart failure Th17 cells Macrophages Autoimmune disease Glucocorticoids CCL21 Adaptive immunity Lamin A/C nuclei Thymoma CXCL13-CXCR5 Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Interféron de type I MG patients Neuromuscular junction Ferrites Maladie auto-immune Fragile X syndromes MiR-7 Inflammatory cytokines Chemokines Etiology Chronic inflammation Chemokine MiR-125 MYB Interferon type I Interferon-β Germinal centers Interferon Clinical cell transplantation Interferonopathy Acetylcholine receptor antibodies Experimental autoimmune myasthenia gravis PBMC LMNA Immunology and Microbiology Section Early-onset myasthenia gravis Immune response Interferon de type I Interleukine-23 COX2 Acetylcholine receptors CD31 Auto-immunité Cytokines Exercise Acetylcholine receptor Quality of life Interferon type-I Cardiomyopathy CTCF Animal models FMR1 Conduction disease Max Centres germinatifs ectopiques